Angiotensin-converting enzyme

AltitudeomicsDB
Protein Official symbol ACE
Aliases ACE DCP DCP1
Chromosomal Location  17
Length 1306
Uniprot ID P12821
EC number 3.2.1.-; 3.4.15.1
Protein family Information(Pfam) PF01401;
PDB id 1O86;1O8A;1UZE;1UZF;2C6F;2C6N;2IUL;2IUX;2OC2;2XY9;2XYD;2YDM;3BKK;3BKL;3L3N;3NXQ;4APH;4APJ;4BXK;4BZR;4BZS;4C2N;4C2O;4C2P;4C2Q;4C2R;4CA5;4CA6;4UFA;4UFB;5AM8;5AM9;5AMA;5AMB;5AMC;6EN5;6EN6;6F9R;6F9T;6F9U;6F9V;6H5W;6H5X;6QS1;
InterPro ID IPR001548;
dbSNP rs13306087 rs12720754 rs3730025 rs4302 rs4303 rs4303 rs989500910 rs2229839 rs56394458 rs13306085 rs12720746 rs4314 rs12709426 rs13306091 rs3730043 rs4976 rs4977 rs12709442 rs121912703 rs4980 rs4364 rs4981 rs4317 rs4318

Protein Protein Interaction

0%
Download Tab separated file
AltitudeomicsDB
Protein 1 Protein 2 Combine Score
AGT REN 0.999
AGTR1 AGT 0.996
AGT ACE 0.996
AGTR2 AGT 0.993
AGT KNG1 0.974
AGTR1 KNG1 0.969
AGTR2 KNG1 0.966
ACE REN 0.959
AGTR1 REN 0.955
ACE KNG1 0.95
AGTR2 REN 0.936
AGTR1 ACE 0.928
AGTR2 ACE 0.926
AGTR1 AGTR2 0.915
REN KNG1 0.904
Gene Ontology Semantic Similarity
Download Tab separated file
# 183 (AGT) 185 (AGTR1) 186 (AGTR2) 1636 (ACE) 5972 (REN) 3827 (KNG1)
183 (AGT) 1.00 0.57 0.58 0.38 0.63 0.73
185 (AGTR1) 0.57 1.00 0.83 0.37 0.53 0.52
186 (AGTR2) 0.58 0.83 1.00 0.32 0.56 0.54
1636 (ACE) 0.38 0.37 0.32 1.00 0.62 0.44
5972 (REN) 0.63 0.53 0.56 0.62 1.00 0.57
3827 (KNG1) 0.73 0.52 0.54 0.44 0.57 1.00
Association with High Altitude
Protein Official symbol Source Organism Tissue of Expression Level of hypoxia Altitude Duration of experiment Level of expression Fold change Experiment details geographical location ethnicity of the patients Control group Control (Fold change) Reference (PMID)
ACE Toad Heart - 3464 m 33 day downregulated -2.052523659 RNA-seq Tibetan Plateau Asiatic toad 1 Zoige (High altitute Toad) Vs Chengdu (Low altitude toad) - 28673260
Association with TF
TF TF Entrez Gene Gene Entrez Type PMID Database
RAD21 5885 ACE 1636 distal 22955619 TRANSFAC
RXRA 6256 ACE 1636 distal 22955619 TRANSFAC
HDAC2 3066 ACE 1636 distal 22955619 TRANSFAC
HNF4A 3172 ACE 1636 distal 22955619 TRANSFAC
EP300 2033 ACE 1636 distal 22955619 TRANSFAC
FOXA2 3170 ACE 1636 distal 22955619 TRANSFAC
FOXA1 3169 ACE 1636 distal 22955619 TRANSFAC
BHLHE40 8553 ACE 1636 distal 22955619 TRANSFAC
CEBPB 1051 ACE 1636 distal 22955619 TRANSFAC
CTCF 10664 ACE 1636 proximal_filtered 22955619 TRANSFAC
CREM 1390 ACE 1636 Unknown 9651321 TRUSST
HIF1A 3091 ACE 1636 Unknown 11095974 TRUSST
EGR1 1958 ACE 1636 Unknown 9651321 TRUSST
SP3 6670 ACE 1636 Unknown 23393140 TRUSST
Association with miRNA
miRTarBase ID miRNA Species (miRNA) Protein Official Symbol Human Entrez ID Species (Target Gene) Experiments Support Type References (PMID)
MIRT018383 hsa-miR-335-5p Homo sapiens ACE 1636 Homo sapiens Microarray Functional MTI (Weak) 18185580
Gene Ontology
ID GO ID GO Term GO Type
1636 GO:0032943 mononuclear cell proliferation GOTERM_BP_DIRECT
1636 GO:0051019 actin filament binding GOTERM_MF_DIRECT
1636 GO:0003081 regulation of systemic arterial blood pressure by renin-angiotensin GOTERM_BP_DIRECT
1636 GO:0001822 kidney development GOTERM_BP_DIRECT
1636 GO:0010629 negative regulation of gene expression GOTERM_BP_DIRECT
1636 GO:0032091 negative regulation of protein binding GOTERM_BP_DIRECT
1636 GO:0050435 beta-amyloid metabolic process GOTERM_BP_DIRECT
1636 GO:0071838 cell proliferation in bone marrow GOTERM_BP_DIRECT
1636 GO:0007283 spermatogenesis GOTERM_BP_DIRECT
1636 GO:0004175 dopachrome isomerase activity GOTERM_MF_DIRECT
1636 GO:0008238 metallopeptidase activity GOTERM_MF_DIRECT
1636 GO:0002005 angiotensin catabolic process in blood GOTERM_BP_DIRECT
1636 GO:1900086 positive regulation of peptidyl-tyrosine autophosphorylation GOTERM_BP_DIRECT
1636 GO:1903597 negative regulation of gap junction assembly GOTERM_BP_DIRECT
1636 GO:2000170 positive regulation of peptidyl-cysteine S-nitrosylation GOTERM_BP_DIRECT
1636 GO:0001974 blood vessel remodeling GOTERM_BP_DIRECT
1636 GO:0003084 positive regulation of systemic arterial blood pressure GOTERM_BP_DIRECT
1636 GO:0061098 positive regulation of protein tyrosine kinase activity GOTERM_BP_DIRECT
1636 GO:0003779 actin binding GOTERM_MF_DIRECT
1636 GO:0031711 endothelin A receptor binding GOTERM_MF_DIRECT
1636 GO:0060177 regulation of angiotensin metabolic process GOTERM_BP_DIRECT
1636 GO:0008237 serine-type peptidase activity GOTERM_MF_DIRECT
1636 GO:0008241 dipeptidyl-peptidase activity GOTERM_MF_DIRECT
1636 GO:0008270 zinc ion binding GOTERM_MF_DIRECT
1636 GO:0031404 sodium ion binding GOTERM_MF_DIRECT
1636 GO:0070573 R-SMAD binding GOTERM_MF_DIRECT
1636 GO:0032092 positive regulation of protein binding GOTERM_BP_DIRECT
1636 GO:0009897 external side of plasma membrane GOTERM_CC_DIRECT
1636 GO:0016021 integral component of membrane GOTERM_CC_DIRECT
1636 GO:0070062 extracellular exosome GOTERM_CC_DIRECT
1636 GO:0002474 antigen processing and presentation of peptide antigen via MHC class I GOTERM_BP_DIRECT
1636 GO:0010608 posttranscriptional regulation of gene expression GOTERM_BP_DIRECT
1636 GO:0019229 regulation of vasoconstriction GOTERM_BP_DIRECT
1636 GO:0042312 regulation of vasodilation GOTERM_BP_DIRECT
1636 GO:0042447 hormone catabolic process GOTERM_BP_DIRECT
1636 GO:0050482 arachidonic acid secretion GOTERM_BP_DIRECT
1636 GO:0005764 lysosome GOTERM_CC_DIRECT
1636 GO:0005886 plasma membrane GOTERM_CC_DIRECT
1636 GO:0004180 aminopeptidase activity GOTERM_MF_DIRECT
1636 GO:0046872 metal ion binding GOTERM_MF_DIRECT
1636 GO:0005768 endosome GOTERM_CC_DIRECT
1636 GO:0002019 regulation of renal output by angiotensin GOTERM_BP_DIRECT
1636 GO:0060047 heart contraction GOTERM_BP_DIRECT
1636 GO:0008144 drug binding GOTERM_MF_DIRECT
1636 GO:0005576 extracellular region GOTERM_CC_DIRECT
1636 GO:0002446 neutrophil mediated immunity GOTERM_BP_DIRECT
1636 GO:0014910 regulation of smooth muscle cell migration GOTERM_BP_DIRECT
1636 GO:0043171 peptide catabolic process GOTERM_BP_DIRECT
1636 GO:0060218 hematopoietic stem cell differentiation GOTERM_BP_DIRECT
1636 GO:1902033 regulation of hematopoietic stem cell proliferation GOTERM_BP_DIRECT
1636 GO:0008240 exopeptidase activity GOTERM_MF_DIRECT
1636 GO:0008217 regulation of blood pressure GOTERM_BP_DIRECT
1636 GO:0016020 membrane GOTERM_CC_DIRECT
1636 GO:0002003 angiotensin maturation GOTERM_BP_DIRECT
1636 GO:0031434 L-ascorbic acid binding GOTERM_MF_DIRECT
1636 GO:0005615 extracellular space GOTERM_CC_DIRECT
Pathways
Human Entrez ID KEGG ID KEGG Term
1636 hsa04614 Renin-angiotensin system
1636 hsa04924 Renin secretion
1636 hsa05142 Chagas disease
1636 hsa05410 Hypertrophic cardiomyopathy
Association with Disease
Protein Official Symbol Human Entrez ID Disease Name Disease Id Disease Semantic Type Semantic score DSI DPI Disease Type
ACE 1636 Presenile dementia C0011265 Mental or Behavioral Dysfunction 0.4 0.367 0.897 disease
ACE 1636 Weight Gain C0043094 Finding 0.3 0.367 0.897 phenotype
ACE 1636 Adenocarcinoma, Basal Cell C0205641 Neoplastic Process 0.3 0.367 0.897 disease
ACE 1636 Adenocarcinoma, Oxyphilic C0205642 Neoplastic Process 0.3 0.367 0.897 disease
ACE 1636 Cardiac Arrhythmia C0003811 Finding 0.31 0.367 0.897 phenotype
ACE 1636 Staphylococcal Infections C0038160 Disease or Syndrome 0.3 0.367 0.897 group
ACE 1636 Paroxysmal atrial fibrillation C0235480 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Coronary Restenosis C0948480 Disease or Syndrome 0.36 0.367 0.897 disease
ACE 1636 Cerebral Hemorrhage C2937358 Pathologic Function 0.31 0.367 0.897 phenotype
ACE 1636 Nonalcoholic Steatohepatitis C3241937 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Alzheimer's Disease C0002395 Disease or Syndrome 0.6 0.367 0.897 disease
ACE 1636 Coronary Arteriosclerosis C0010054 Disease or Syndrome 0.4 0.367 0.897 disease
ACE 1636 Diabetes Mellitus, Experimental C0011853 Experimental Model of Disease 0.3 0.367 0.897 disease
ACE 1636 Drug Allergy C0013182 Pathologic Function 0.31 0.367 0.897 phenotype
ACE 1636 Nodular glomerulosclerosis C0017667 Disease or Syndrome 0.33 0.367 0.897 disease
ACE 1636 Pneumonia, Viral C0032310 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Atrial Fibrillation C0004238 Disease or Syndrome 0.4 0.367 0.897 disease
ACE 1636 Sudden death C0011071 Pathologic Function 0.3 0.367 0.897 phenotype
ACE 1636 Hypotension C0020649 Finding 0.4 0.367 0.897 phenotype
ACE 1636 Kidney Diseases C0022658 Disease or Syndrome 0.4 0.367 0.897 group
ACE 1636 Lung diseases C0024115 Disease or Syndrome 0.54 0.367 0.897 group
ACE 1636 Heart failure C0018801 Disease or Syndrome 0.6 0.367 0.897 disease
ACE 1636 Cerebrovascular accident C0038454 Disease or Syndrome 0.4 0.367 0.897 group
ACE 1636 Left Ventricular Hypertrophy C0149721 Disease or Syndrome 0.4 0.367 0.897 disease
ACE 1636 Brain Ischemia C0007786 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Glycogen Storage Disease Type V C0017924 Disease or Syndrome 0.34 0.367 0.897 disease
ACE 1636 Meningococcal Infections C0025303 Disease or Syndrome 0.32 0.367 0.897 group
ACE 1636 Familial Alzheimer Disease (FAD) C0276496 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Acute Confusional Senile Dementia C0546126 Mental or Behavioral Dysfunction 0.3 0.367 0.897 disease
ACE 1636 Severe Acute Respiratory Syndrome C1175175 Disease or Syndrome 0.32 0.367 0.897 disease
ACE 1636 Persistent atrial fibrillation C2585653 Pathologic Function 0.3 0.367 0.897 phenotype
ACE 1636 Berylliosis C0005138 Injury or Poisoning 0.3 0.367 0.897 disease
ACE 1636 Coughing C0010200 Sign or Symptom 0.4 0.367 0.897 phenotype
ACE 1636 Kidney Failure, Chronic C0022661 Disease or Syndrome 0.6 0.367 0.897 disease
ACE 1636 Pre-Eclampsia C0032914 Pathologic Function 0.34 0.367 0.897 phenotype
ACE 1636 Staphylococcus aureus infection C1318973 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Hereditary Diffuse Gastric Cancer C1708349 Neoplastic Process 0.3 0.367 0.897 disease
ACE 1636 Coronary Artery Disease C1956346 Disease or Syndrome 0.4 0.367 0.897 disease
ACE 1636 Left-Sided Heart Failure C0023212 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Myocardial Infarction C0027051 Disease or Syndrome 0.6 0.367 0.897 disease
ACE 1636 Streptozotocin Diabetes C0038433 Experimental Model of Disease 0.3 0.367 0.897 disease
ACE 1636 Malignant neoplasm of lung C0242379 Neoplastic Process 0.31 0.367 0.897 disease
ACE 1636 Gaucher Disease, Type 2 (disorder) C0268250 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Malignant neoplasm of prostate C0376358 Neoplastic Process 0.34 0.367 0.897 disease
ACE 1636 Gaucher Disease, Type 3 (disorder) C0268251 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Alzheimer Disease, Early Onset C0750901 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Adenocarcinoma C0001418 Neoplastic Process 0.3 0.367 0.897 group
ACE 1636 IGA Glomerulonephritis C0017661 Disease or Syndrome 0.4 0.367 0.897 disease
ACE 1636 Hypertensive disease C0020538 Disease or Syndrome 0.6 0.367 0.897 group
ACE 1636 Infant, Premature, Diseases C0021295 Disease or Syndrome 0.3 0.367 0.897 group
ACE 1636 Lung Neoplasms C0024121 Neoplastic Process 0.31 0.367 0.897 group
ACE 1636 Heart Decompensation C1961112 Pathologic Function 0.3 0.367 0.897 phenotype
ACE 1636 Liver carcinoma C2239176 Neoplastic Process 0.37 0.367 0.897 disease
ACE 1636 Acute Cerebrovascular Accidents C0751956 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Cardiovascular Diseases C0007222 Disease or Syndrome 0.4 0.367 0.897 group
ACE 1636 Congestive heart failure C0018802 Disease or Syndrome 0.6 0.367 0.897 disease
ACE 1636 Prostatic Neoplasms C0033578 Neoplastic Process 0.31 0.367 0.897 group
ACE 1636 Respiratory Tract Diseases C0035242 Disease or Syndrome 0.3 0.367 0.897 group
ACE 1636 Vascular System Injuries C0178324 Injury or Poisoning 0.3 0.367 0.897 group
ACE 1636 Alzheimer's Disease, Focal Onset C0750900 Mental or Behavioral Dysfunction 0.3 0.367 0.897 disease
ACE 1636 Alzheimer Disease, Late Onset C0494463 Mental or Behavioral Dysfunction 0.35 0.367 0.897 disease
ACE 1636 Renal Insufficiency C1565489 Disease or Syndrome 0.39 0.367 0.897 disease
ACE 1636 Beryllium Disease C2350873 Disease or Syndrome 0.31 0.367 0.897 disease
ACE 1636 MICROVASCULAR COMPLICATIONS OF DIABETES, SUSCEPTIBILITY TO, 3 (finding) C2675470 Finding 0.3 0.367 0.897 phenotype
ACE 1636 Albuminuria C0001925 Finding 0.31 0.367 0.897 phenotype
ACE 1636 Gaucher Disease C0017205 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Malignant neoplasm of stomach C0024623 Neoplastic Process 0.36 0.367 0.897 disease
ACE 1636 Psychoses, Substance-Induced C0033941 Mental or Behavioral Dysfunction 0.3 0.367 0.897 disease
ACE 1636 Kidney Failure C0035078 Disease or Syndrome 0.4 0.367 0.897 disease
ACE 1636 Adenocarcinoma, Tubular C0205645 Neoplastic Process 0.3 0.367 0.897 disease
ACE 1636 familial atrial fibrillation C3468561 Pathologic Function 0.3 0.367 0.897 phenotype
ACE 1636 Autistic Disorder C0004352 Mental or Behavioral Dysfunction 0.31 0.367 0.897 group
ACE 1636 Pulmonary Hypertension C0020542 Pathologic Function 0.32 0.367 0.897 phenotype
ACE 1636 Neoplasm Metastasis C0027627 Neoplastic Process 0.33 0.367 0.897 phenotype
ACE 1636 Diabetic Nephropathy C0011881 Disease or Syndrome 0.4 0.367 0.897 disease
ACE 1636 Male infertility C0021364 Disease or Syndrome 0.32 0.367 0.897 disease
ACE 1636 Stomach Neoplasms C0038356 Neoplastic Process 0.32 0.367 0.897 group
ACE 1636 Carcinoma, Cribriform C0205643 Neoplastic Process 0.3 0.367 0.897 disease
ACE 1636 Non-alcoholic Fatty Liver Disease C0400966 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Male sterility C0917731 Finding 0.3 0.367 0.897 phenotype
ACE 1636 Cerebral Ischemia C0917798 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Myocardial Failure C1959583 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Gaucher Disease, Type 1 C1961835 Disease or Syndrome 0.31 0.367 0.897 disease
ACE 1636 Alloxan Diabetes C0002152 Experimental Model of Disease 0.3 0.367 0.897 disease
ACE 1636 Coronary heart disease C0010068 Disease or Syndrome 0.4 0.367 0.897 disease
ACE 1636 Psychoses, Drug C0033937 Mental or Behavioral Dysfunction 0.3 0.367 0.897 disease
ACE 1636 Carcinoma, Granular Cell C0205644 Neoplastic Process 0.3 0.367 0.897 disease
ACE 1636 Heart Failure, Right-Sided C0235527 Disease or Syndrome 0.3 0.367 0.897 disease
ACE 1636 Subfertility, Male C0848676 Sign or Symptom 0.3 0.367 0.897 phenotype
ACE 1636 Allanson Pantzar McLeod syndrome C0266313 Disease or Syndrome 0.64 0.367 0.897 disease
ACE 1636 Renal Tubular Dysgenesis With Choanal Atresia And Athelia C2678367 Disease or Syndrome 0.5 0.367 0.897 disease
ACE 1636 Hypercholesterolemia, Familial C0020445 Disease or Syndrome 0.32 0.367 0.897 disease
ACE 1636 Cerebrovascular Disorders C0007820 Disease or Syndrome 0.4 0.367 0.897 group
ACE 1636 Bipolar Disorder C0005586 Mental or Behavioral Dysfunction 0.55 0.367 0.897 disease
ACE 1636 Alcoholic Intoxication, Chronic C0001973 Mental or Behavioral Dysfunction 0.32 0.367 0.897 disease
ACE 1636 Depressed mood C0344315 Finding 0.3 0.367 0.897 phenotype
ACE 1636 Schizophrenia C0036341 Mental or Behavioral Dysfunction 0.4 0.367 0.897 disease
ACE 1636 Depressive Symptoms C0086132 Sign or Symptom 0.32 0.367 0.897 phenotype
ACE 1636 Chronic schizophrenia C0221765 Mental or Behavioral Dysfunction 0.33 0.367 0.897 disease
ACE 1636 Depressive disorder C0011581 Mental or Behavioral Dysfunction 0.4 0.367 0.897 disease
ACE 1636 Major Depressive Disorder C1269683 Mental or Behavioral Dysfunction 0.4 0.367 0.897 disease
ACE 1636 H/O: depression C0455503 Finding 0.3 0.367 0.897 phenotype
ACE 1636 MAJOR AFFECTIVE DISORDER 2 C1839839 Mental or Behavioral Dysfunction 0.01 0.367 0.897 disease
ACE 1636 Unipolar Depression C0041696 Mental or Behavioral Dysfunction 0.4 0.367 0.897 disease
Association with Drug
Protein Official Symbol Human Entrez ID drug_claim_primary_name drug_name drug_chembl_id interaction_types
ACE 1636 BENAZEPRIL HYDROCHLORIDE BENAZEPRIL HYDROCHLORIDE CHEMBL1694 inhibitor
ACE 1636 BENAZEPRIL BENAZEPRIL CHEMBL838 inhibitor
ACE 1636 BENAZEPRIL BENAZEPRIL CHEMBL838 None
ACE 1636 BENAZEPRIL BENAZEPRIL CHEMBL838 None
ACE 1636 BENAZEPRILAT BENAZEPRILAT CHEMBL1192519 inhibitor
ACE 1636 CANDOXATRIL CANDOXATRIL CHEMBL35084 None
ACE 1636 CANDOXATRIL CANDOXATRIL CHEMBL35084 None
ACE 1636 CAPTOPRIL CAPTOPRIL CHEMBL1560 None
ACE 1636 CAPTOPRIL CAPTOPRIL CHEMBL1560 None
ACE 1636 CAPTOPRIL CAPTOPRIL CHEMBL1560 inhibitor
ACE 1636 CAPTOPRIL CAPTOPRIL CHEMBL1560 inhibitor
ACE 1636 CAPTOPRIL CAPTOPRIL CHEMBL1560 None
ACE 1636 CILAZAPRIL CILAZAPRIL CHEMBL515606 inhibitor
ACE 1636 CILAZAPRIL CILAZAPRIL CHEMBL515606 None
ACE 1636 CILAZAPRIL CILAZAPRIL CHEMBL515606 None
ACE 1636 DESERPIDINE DESERPIDINE CHEMBL1200515 None
ACE 1636 DESERPIDINE DESERPIDINE CHEMBL1200515 None
ACE 1636 ENALAPRIL ENALAPRIL CHEMBL578 inhibitor
ACE 1636 ENALAPRIL MALEATE ENALAPRIL MALEATE CHEMBL1200659 inhibitor
ACE 1636 ENALAPRIL ENALAPRIL CHEMBL578 None
ACE 1636 ENALAPRILAT ENALAPRILAT CHEMBL577 inhibitor
ACE 1636 ENALAPRIL MALEATE ENALAPRIL MALEATE CHEMBL1200659 None
ACE 1636 ENALAPRILAT HYDRATE ENALAPRILAT HYDRATE CHEMBL1200697 inhibitor
ACE 1636 ENALAPRIL ENALAPRIL CHEMBL578 None
ACE 1636 ENZYME INHIBITOR None None None
ACE 1636 FASIDOTRIL FASIDOTRIL CHEMBL2106226 inhibitor
ACE 1636 FASIDOTRILAT FASIDOTRILAT CHEMBL325055 inhibitor
ACE 1636 FOSINOPRIL FOSINOPRIL CHEMBL3039598 None
ACE 1636 FOSINOPRIL FOSINOPRIL CHEMBL3039598 inhibitor
ACE 1636 FOSINOPRIL FOSINOPRIL CHEMBL3039598 None
ACE 1636 FOSINOPRIL SODIUM FOSINOPRIL SODIUM CHEMBL3039596 inhibitor
ACE 1636 GLUCOCORTICOID None None None
ACE 1636 ILEPATRIL CHEMBL3187812 CHEMBL3187812 None
ACE 1636 IMIDAPRIL IMIDAPRIL CHEMBL317094 inhibitor
ACE 1636 IMIDAPRILAT IMIDAPRILAT CHEMBL99701 inhibitor
ACE 1636 INDOMETHACIN INDOMETHACIN CHEMBL6 None
ACE 1636 LISINOPRIL LISINOPRIL CHEMBL1237 None
ACE 1636 LISINOPRIL-TRYPTOPHAN None None inhibitor
ACE 1636 LISINOPRIL LISINOPRIL CHEMBL1237 inhibitor
ACE 1636 LISINOPRIL LISINOPRIL CHEMBL1237 None
ACE 1636 LISINOPRIL HYDRATE LISINOPRIL HYDRATE CHEMBL1729579 inhibitor
ACE 1636 MOEXIPRIL HYDROCHLORIDE MOEXIPRIL HYDROCHLORIDE CHEMBL1200534 inhibitor
ACE 1636 MOEXIPRIL MOEXIPRIL CHEMBL1165 None
ACE 1636 MOEXIPRIL MOEXIPRIL CHEMBL1165 None
ACE 1636 MOEXIPRIL MOEXIPRIL CHEMBL1165 inhibitor
ACE 1636 PERINDOPRIL PERINDOPRIL CHEMBL1581 None
ACE 1636 PERINDOPRIL ARGININE PERINDOPRIL ARGININE CHEMBL3544986 inhibitor
ACE 1636 PERINDOPRIL PERINDOPRIL CHEMBL1581 None
ACE 1636 PERINDOPRIL ERBUMINE PERINDOPRIL ERBUMINE CHEMBL1200343 inhibitor
ACE 1636 PERINDOPRILAT PERINDOPRILAT CHEMBL1201368 inhibitor
ACE 1636 PERINDOPRIL PERINDOPRIL CHEMBL1581 inhibitor
ACE 1636 QUINAPRIL HYDROCHLORIDE QUINAPRIL HYDROCHLORIDE CHEMBL1201011 inhibitor
ACE 1636 QUINAPRIL QUINAPRIL CHEMBL1592 None
ACE 1636 QUINAPRIL QUINAPRIL CHEMBL1592 None
ACE 1636 QUINAPRILAT QUINAPRILAT CHEMBL1733 inhibitor
ACE 1636 RAMIPRIL RAMIPRIL CHEMBL1168 None
ACE 1636 RAMIPRIL RAMIPRIL CHEMBL1168 inhibitor
ACE 1636 RAMIPRILAT RAMIPRILAT CHEMBL1201365 inhibitor
ACE 1636 RAMIPRIL RAMIPRIL CHEMBL1168 inhibitor
ACE 1636 RAMIPRIL RAMIPRIL CHEMBL1168 None
ACE 1636 RESCINNAMINE RESCINNAMINE CHEMBL1668 None
ACE 1636 RESCINNAMINE RESCINNAMINE CHEMBL1668 None
ACE 1636 RXP-407 CHEMBL1235767 CHEMBL1235767 inhibitor
ACE 1636 SPIRAPRIL HYDROCHLORIDE SPIRAPRIL HYDROCHLORIDE CHEMBL1200831 inhibitor
ACE 1636 SPIRAPRILAT SPIRAPRILAT CHEMBL579 inhibitor
ACE 1636 SPIRAPRIL SPIRAPRIL CHEMBL431 None
ACE 1636 SPIRAPRIL SPIRAPRIL CHEMBL431 None
ACE 1636 SPIRAPRIL SPIRAPRIL CHEMBL431 inhibitor
ACE 1636 TRANDOLAPRIL TRANDOLAPRIL CHEMBL1519 inhibitor
ACE 1636 TRANDOLAPRIL TRANDOLAPRIL CHEMBL1519 None
ACE 1636 TRANDOLAPRIL TRANDOLAPRIL CHEMBL1519 inhibitor
ACE 1636 TRANDOLAPRILAT TRANDOLAPRILAT CHEMBL1201387 inhibitor
ACE 1636 TRANDOLAPRIL TRANDOLAPRIL CHEMBL1519 None
ACE 1636 VASOPRESSIN VASOPRESSIN CHEMBL373742 None
ACE 1636 ZOFENOPRIL ZOFENOPRIL CHEMBL331378 inhibitor